Artwork

محتوای ارائه شده توسط ResearchPod. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط ResearchPod یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal
Player FM - برنامه پادکست
با برنامه Player FM !

Next-gen Probiotics for Gut Health | The Enterprise Sessions with Jenny Bailey

37:18
 
اشتراک گذاری
 

Manage episode 414254894 series 2680968
محتوای ارائه شده توسط ResearchPod. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط ResearchPod یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal

How can spin-outs leverage end user feedback to refine products and validate markets? Find out as Professor Michele Barbour talks to Dr Jenny Bailey, the CEO and Co-Founder of Ferryx, a biotech company focused on the commercial production of live bacterial products for the prevention and treatment of gastrointestinal inflammation in humans and animals.

Highlights

§ Discover how a chance conversation with Co-Founder Dr Tristan Cogan sparked the innovative idea behind Ferryx: the disruption of inflammatory pathways in the gut using live bacteria that flourish in the presence of iron.

§ Find out about the steps Jenny and Tristan took to protect their new intellectual property and take it from the lab to a commercial product

§ Jenny gives her perspective on the pre-accelerator ICURe programme, which encouraged her to step out of her comfort zone, engage with stakeholders, refine the project and test its market viability.

§ Hear about Ferryx’s approach to ongoing product development and testing, including clinical trials and engagement with patient feedback.

🌐 About the Enterprise Sessions

The Enterprise Sessions bring together a diverse mix of company founders and researchers who talk openly about their personal experiences of forming spin-outs and start-ups, raising capital, academic-industry partnerships and the joys of translating research discoveries into real-world impact.

The series aims to inform, inspire and challenge myths and stereotypes about research commercialisation and how businesses and universities can work together to tackle society's biggest challenges.

👍 Like, Share, Subscribe, Explore

If you found this episode inspiring or informative, please don’t forget to like and share. Visit our website or subscribe to the University of Bristol’s YouTube channel for more Enterprise Sessions.

https://www.bristol.ac.uk/enterprise-sessions

🔗 Connect with Ferryx

Ferryx website: https://www.ferryx.com/

Ferryx on LinkedIn: https://www.linkedin.com/company/ferryx/

Ferryx on X: https://twitter.com/ferryx_bristol

  continue reading

371 قسمت

Artwork
iconاشتراک گذاری
 
Manage episode 414254894 series 2680968
محتوای ارائه شده توسط ResearchPod. تمام محتوای پادکست شامل قسمت‌ها، گرافیک‌ها و توضیحات پادکست مستقیماً توسط ResearchPod یا شریک پلتفرم پادکست آن‌ها آپلود و ارائه می‌شوند. اگر فکر می‌کنید شخصی بدون اجازه شما از اثر دارای حق نسخه‌برداری شما استفاده می‌کند، می‌توانید روندی که در اینجا شرح داده شده است را دنبال کنید.https://fa.player.fm/legal

How can spin-outs leverage end user feedback to refine products and validate markets? Find out as Professor Michele Barbour talks to Dr Jenny Bailey, the CEO and Co-Founder of Ferryx, a biotech company focused on the commercial production of live bacterial products for the prevention and treatment of gastrointestinal inflammation in humans and animals.

Highlights

§ Discover how a chance conversation with Co-Founder Dr Tristan Cogan sparked the innovative idea behind Ferryx: the disruption of inflammatory pathways in the gut using live bacteria that flourish in the presence of iron.

§ Find out about the steps Jenny and Tristan took to protect their new intellectual property and take it from the lab to a commercial product

§ Jenny gives her perspective on the pre-accelerator ICURe programme, which encouraged her to step out of her comfort zone, engage with stakeholders, refine the project and test its market viability.

§ Hear about Ferryx’s approach to ongoing product development and testing, including clinical trials and engagement with patient feedback.

🌐 About the Enterprise Sessions

The Enterprise Sessions bring together a diverse mix of company founders and researchers who talk openly about their personal experiences of forming spin-outs and start-ups, raising capital, academic-industry partnerships and the joys of translating research discoveries into real-world impact.

The series aims to inform, inspire and challenge myths and stereotypes about research commercialisation and how businesses and universities can work together to tackle society's biggest challenges.

👍 Like, Share, Subscribe, Explore

If you found this episode inspiring or informative, please don’t forget to like and share. Visit our website or subscribe to the University of Bristol’s YouTube channel for more Enterprise Sessions.

https://www.bristol.ac.uk/enterprise-sessions

🔗 Connect with Ferryx

Ferryx website: https://www.ferryx.com/

Ferryx on LinkedIn: https://www.linkedin.com/company/ferryx/

Ferryx on X: https://twitter.com/ferryx_bristol

  continue reading

371 قسمت

All episodes

×
 
Loading …

به Player FM خوش آمدید!

Player FM در سراسر وب را برای یافتن پادکست های با کیفیت اسکن می کند تا همین الان لذت ببرید. این بهترین برنامه ی پادکست است که در اندروید، آیفون و وب کار می کند. ثبت نام کنید تا اشتراک های شما در بین دستگاه های مختلف همگام سازی شود.

 

راهنمای مرجع سریع